IA
RCUS icon

IFP Advisors’s Arcus Biosciences RCUS Stock Holding History

IFP Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$389 Hold
18
– – ﹤0.01% 4482
2025
Q4 		$429 Hold
18
– – ﹤0.01% 4324
2025
Q3 		$245 Buy
+18
New +$187 ﹤0.01% 4355
2025
Q2 		– Hold
0
– – – 4178
2025
Q1 		– Sell
-65
Closed -$754 – 4195
2024
Q4 		$1.03K Buy
+65
New +$1.06K ﹤0.01% 3270

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

IFP Advisors's RCUS Position: Q1 2026 in Review

IFP Advisors held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 18 shares worth $389. The position accounts for ﹤0.01% of the portfolio, ranked #4482.

IFP Advisors first reported a position in RCUS in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.03K in Q4 2024. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • IFP Advisors held 18 shares of Arcus Biosciences worth $389 as of Q1 2026.
  • IFP Advisors left its Arcus Biosciences share count unchanged in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4482 holding.
  • IFP Advisors first reported a position in Arcus Biosciences in Q4 2024 and has held it in 4 quarters since.
  • IFP Advisors's Arcus Biosciences position peaked at $1.03K in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.